According to my research and the annual report published few weeks ago: - IDE submission in Q125, ie in the next few days - Response by FDA within 30 days of submission - If IDE is approved, recruitment should start for the pivotal trial around May/ June 25 - as we will receive around US$25,000 for each implant, so technically speaking we will be generating revenue - PMA could be by the end of 2027
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)